ConductScience.org, home

Paper41374333

Quantitative CT Perfusion and Radiomics Reveal Complementary Markers of Treatment Response in HCC Patients Undergoing TACE.

Fezoulidis N and 4 others. Diagnostics (Basel), 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Quantitative CT Perfusion and Radiomics Reveal Complementary Markers of Treatment Response in HCC Patients Undergoing TACE. Papers, record 41374333. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41374333

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Quantitative CT Perfusion and Radiomics Reveal Complementary Markers of Treatment Response in HCC Patients Undergoing TACE.
PubMed
Journal
Diagnostics (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-12-14
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fezoulidis NNicolas
2Slavicek JJakob
3Nonninger JNJulian-Niklashttps://orcid.org/0000-0002-8171-0500
4Hergan KKlaushttps://orcid.org/0009-0005-6571-8296
5Zandieh SShahinhttps://orcid.org/0000-0002-0177-4249

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126579733Radiomics: Images Are More than Pictures, They Are Data.Radiology2016https://conductscience.org/library/papers/26579733PubMed
229307467Hepatocellular carcinoma.Lancet2018https://conductscience.org/library/papers/29307467PubMed
333538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
420175034Current strategy for staging and treatment: the BCLC update and future prospects.Semin Liver Dis2010https://conductscience.org/library/papers/20175034PubMed
532154773The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.Radiology2020https://conductscience.org/library/papers/32154773PubMed
632233054Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.J Magn Reson Imaging2020https://conductscience.org/library/papers/32233054PubMed
733708638Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma.Liver Cancer2021https://conductscience.org/library/papers/33708638PubMed
820175033Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.Semin Liver Dis2010https://conductscience.org/library/papers/20175033PubMed
934801630BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.J Hepatol2022https://conductscience.org/library/papers/34801630PubMed
1022257792Radiomics: extracting more information from medical images using advanced feature analysis.Eur J Cancer2012https://conductscience.org/library/papers/22257792PubMed
1136943423Computed tomography texture analysis combined with preoperative clinical factors serve as a predictor of early efficacy of transcatheter arterial chemoembolization in hepatocellular carcinoma.Abdom Radiol (NY)2023https://conductscience.org/library/papers/36943423PubMed
1222086560Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.Eur Radiol2012https://conductscience.org/library/papers/22086560PubMed
1338076381Role of Computed Tomography Perfusion in Patients with Liver Cirrhosis and Hepatocellular Carcinoma.J Clin Exp Hepatol2024https://conductscience.org/library/papers/38076381PubMed
1419097774New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer2009https://conductscience.org/library/papers/19097774PubMed
1517517931Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.Radiology2007https://conductscience.org/library/papers/17517931PubMed
1639086938Enhancing prognostic prediction in hepatocellular carcinoma post-TACE: a machine learning approach integrating radiomics and clinical features.Front Med (Lausanne)2024https://conductscience.org/library/papers/39086938PubMed
1735896687Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma.Cardiovasc Intervent Radiol2022https://conductscience.org/library/papers/35896687PubMed
1834745952Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning.Front Oncol2021https://conductscience.org/library/papers/34745952PubMed
1930887739Hepatocellular Carcinoma: Texture Analysis of Preoperative Computed Tomography Images Can Provide Markers of Tumor Grade and Disease-Free Survival.Korean J Radiol2019https://conductscience.org/library/papers/30887739PubMed
2034918174Radiomics analysis of pretreatment MRI in predicting tumor response and outcome in hepatocellular carcinoma with transarterial chemoembolization: a two-center collaborative study.Abdom Radiol (NY)2022https://conductscience.org/library/papers/34918174PubMed

See all 27 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41374333

GET https://conductscience.org/api/papers/v1/41374333/references?page=2